Microneedling requires more commitment and post-procedure care
Packaging looks ok
GLP-1, GIP & Inflammation: What These Medications Really Do and What They Dont Joshua Silva, MD Dec 5, 2025 7 min read Updated: Jan 27 Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD Quick Answer GLP-1 and GLP-1/GIP medications (such as semaglutide and tirzepatide ) can lower metabolic inflammation by improving insulin resistance, reducing visceral fat, and lowering inflammatory biomarkers such as C-reactive protein (CRP) ., They can also improve cardiometabolic risk markers (e.g., blood pressure) and, for tirzepatide, can improve atherogenic lipoprotein measures including apoB and triglyceride-rich lipoproteins in clinical research settings., They do not treat autoimmune diseases or fibromyalgia directly
Beyond its approved indication, PT-141 has been investigated and used off-label for male erectile dysfunction, particularly in men who don't respond to PDE5 inhibitors or have contraindications to their use
knows how to provide treatments that suit your actual needs and skip unnecessary guessing
But theres been less focus on how tirzepatide might be able to mitigate the risk of such issues
